Investing

Sutro Biopharma : STRO

STRO

Stock Data

$35.59

$1.03 (2.81%)

Asset Type

Common Stock

Exchange

NASDAQ

Currency

USD

Country

USA

Sector

HEALTHCARE

Industry

BIOTECHNOLOGY

Sutro Biopharma Inc is a pioneering clinical-stage company focused on the development of innovative cancer treatments. It specializes in creating antibody drug conjugates (ADCs) with its unique cell-free protein synthesis platforms, XpressCF and XpressCF+. The company is advancing a portfolio of product candidates targeting various cancers, including multiple myeloma, non-Hodgkin lymphoma, ovarian, and endometrial cancers. Sutro Biopharma is also engaged in strategic collaborations with industry leaders to enhance its research in immuno-oncology and solid tumors, demonstrating its commitment to advancing cancer care.

All Sutro Biopharma Articles

1 Article

Jon C. Ogg | Aug 7, 2020 at 9:11 AM EDT

Top Analyst Upgrades and Downgrades: Alteryx, Booking, CarGurus, Datadog, FedEx, First Solar, Uber, Vonage, Yeti, Zillow and More

Friday's top analyst upgrades and downgrades included Alteryx, Booking, CarGurus, Datadog, FedEx, First Solar, Uber Technologies, Vonage, Yeti and Zillow.